Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Single-institutional Cancer Registry
Status
Conditions
Treatments
Details and patient eligibility
About
Real-world studies on long-term prognosis in patients who underwent anti-tumor treatments during hospitalization from a hospital-based cancer registry in china.
Full description
This is a single-center continuous enrollment cohort study. The overall survival and disease-free survival of patients with malignant tumors in the target tumor hospital undergoing surgery, radiotherapy, chemotherapy, and immunotherapy were observed. Follow-up methods include medical records review, telephone call interview, and data linkage to the related provincial death certificate registries. This study will provide real world data-sets for researches on long-term survival and prognosis of cancer patients, and expend exploration on the cancer survival determinants both from clinical and social-economic prospective.
Enrollment
Sex
Volunteers
Inclusion criteria
- All patients who completed tumor treatment (including surgery, radiotherapy, chemotherapy, immunotherapy, etc.) due to malignant tumors based on preoperative or intraoperative evaluation in Fudan University Shanghai Cancer Center during the study period.
Exclusion criteria
- Patients who have not been treated during hospitalization;
- Patients with non-malignant tumors.
Trial design
500,000 participants in 1 patient group
Trial contacts and locations
Loading...
Central trial contact
Ying Zheng, Dr.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal